How to buy ViewRay stock | $5.79

ViewRay, Inc is a medical devices business based in the US. ViewRay shares (VRAY) are listed on the NASDAQ and all prices are listed in US Dollars. ViewRay employs 236 staff and has a trailing 12-month revenue of around 0.00.

ViewRay stock price (NASDAQ: VRAY)

Use our graph to track the performance of VRAY stocks over time.

ViewRay shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$5.79
52-week range	$2.46 - $7.36
50-day moving average	$6.36
200-day moving average	$5.27
Wall St. target price	$6.78
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.21

Buy ViewRay shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy ViewRay stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ViewRay, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ViewRay price performance over time

Historical closes compared with the close of $5.79 from 2021-05-26

1 week (2021-07-23)	N/A
1 month (2021-07-02)	-11.74%
3 months (2021-05-03)	19.14%
6 months (2021-01-30)	N/A

1 year (2020-07-30)	N/A
2 years (2019-07-30)	N/A
3 years (2018-07-30)	N/A
5 years (2016-07-30)	N/A

ViewRay financials

Revenue TTM	$58.3 million
Gross profit TTM	$-4,059,000
Return on assets TTM	-20.73%
Return on equity TTM	-59.77%
Profit margin	-183.76%
Book value	$1.02
Market capitalisation	$1.1 billion

TTM: trailing 12 months

Shorting ViewRay shares

There are currently 10.3 million ViewRay shares held short by investors – that's known as ViewRay's "short interest". This figure is 0.1% up from 10.3 million last month.

There are a few different ways that this level of interest in shorting ViewRay shares can be evaluated.

ViewRay's "short interest ratio" (SIR)

ViewRay's "short interest ratio" (SIR) is the quantity of ViewRay shares currently shorted divided by the average quantity of ViewRay shares traded daily (recently around 1.4 million). ViewRay's SIR currently stands at 7.4. In other words for every 100,000 ViewRay shares traded daily on the market, roughly 7400 shares are currently held short.

However ViewRay's short interest can also be evaluated against the total number of ViewRay shares, or, against the total number of tradable ViewRay shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ViewRay's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 ViewRay shares in existence, roughly 60 shares are currently held short) or 0.0893% of the tradable shares (for every 100,000 tradable ViewRay shares, roughly 89 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ViewRay.

Find out more about how you can short ViewRay stock.

ViewRay share dividends

We're not expecting ViewRay to pay a dividend over the next 12 months.

Have ViewRay's shares ever split?

ViewRay's shares were split on 7 July 2015.

ViewRay share price volatility

Over the last 12 months, ViewRay's shares have ranged in value from as little as $2.46 up to $7.36. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ViewRay's is 1.0239. This would suggest that ViewRay's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ViewRay overview

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network.

Frequently asked questions

What percentage of ViewRay is owned by insiders or institutions?
Currently 3.013% of ViewRay shares are held by insiders and 95.685% by institutions. How many people work for ViewRay?
Latest data suggests 236 work at ViewRay. When does the fiscal year end for ViewRay?
ViewRay's fiscal year ends in December. Where is ViewRay based?
ViewRay's address is: 2 Thermo Fisher Way, Oakwood, OH, United States, 44146 What is ViewRay's ISIN number?
ViewRay's international securities identification number is: US92672L1070 What is ViewRay's CUSIP number?
ViewRay's Committee on Uniform Securities Identification Procedures number is: 92672L107